| III, Charles F Reynolds |
| Active, not recruiting | 1/2 | 130 | Canada, US | IMNN-001, Carboplatin, Paclitaxel | Imunon | Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer | 07/24 | 11/25 | | |
|
| Marrouche, Nassir F |
EDORA, NCT04704050: Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence |
|
|
| Terminated | 4 | 22 | US | dronedarone 400 mg Oral Tablet, Multaq®, Placebo | Tulane University School of Medicine, University of Washington, Marrek, INC, Sanofi, Preventice, Mckesson | Atrial Fibrillation, Atrial Fibrillation Recurrent | 12/22 | 12/22 | | |
FROZEN-AF, NCT04133168: Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation |
|
|
| Completed | N/A | 458 | Europe, Canada, US, RoW | Boston Scientific Cardiac Cryoablation System | Boston Scientific Corporation | Paroxysmal Atrial Fibrillation | 11/22 | 08/23 | | |
| Recruiting | N/A | 10000 | US | Smartwatch | Tulane University, Samsung Electronics | Heart Diseases | 10/27 | 10/27 | | |
TiPP, NCT04703166: Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy. |
|
|
| Not yet recruiting | N/A | 300 | US | Samsung Galaxy Watch Active2 | Tulane University School of Medicine, Samsung, Preventice | Atrial Fibrillation | 12/27 | 12/27 | | |
LUX-Dx TRENDS, NCT04790344: Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System. |
|
|
| Active, not recruiting | N/A | 525 | US | Investigational LUX-Dx ICM Implant | Boston Scientific Corporation | Heart Failure | 05/26 | 06/26 | | |
| Fuloria, Jyotsna |
| Recruiting | 4 | 150 | US | Human papillomavirus 9-valent vaccine, recombinant, Gardasil-9 | Louisiana State University Health Sciences Center in New Orleans, Merck Sharp & Dohme LLC | Papillomavirus Vaccines, Human Immunodeficiency Virus, Papillomavirus Infection, Serology, Cervical Intraepithelial Neoplasia, Anal Intraepithelial Neoplasia, Oral Cavity Infection | 06/24 | 03/25 | | |
| Active, not recruiting | 2/3 | 429 | Europe, US, RoW | Osivelotor, PF-07940367 or GBT021601 | Pfizer, Pfizer | Sickle Cell Disease | 10/28 | 10/28 | | |
ACCRU-GI-2008, NCT05168163: Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer |
|
|
| Recruiting | 2 | 122 | US | Atezolizumab, MPDL 3280A, MPDL 328OA, MPDL-3280A, MPDL3280A, MPDL328OA, RG7446, RO5541267, Tecentriq, Cabozantinib, Lenvatinib, E7080, ER-203492-00, Multi-Kinase Inhibitor E7080 | Academic and Community Cancer Research United, National Cancer Institute (NCI), Genentech, Inc. | Locally Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8, Stage IVA Hepatocellular Carcinoma AJCC v8, Stage IVB Hepatocellular Carcinoma AJCC v8, Unresectable Hepatocellular Carcinoma | 12/24 | 12/26 | | |
NCT05249101: A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma |
|
|
| Recruiting | 1/2 | 70 | US | Ivaltinostat, Capecitabine, Xeloda | CG Pharmaceuticals, Inc | Metastatic Pancreatic Adenocarcinoma | 02/26 | 06/26 | | |
| Active, not recruiting | 1/2 | 195 | US | BXQ-350, SapC-DOPS, Placebo | Bexion Pharmaceuticals, Inc., ICON plc, CTI Clinical Trial and Consulting Services | Metastatic Colorectal Carcinoma, Neuropathy | 04/26 | 04/29 | | |
NCT06451497: Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors |
|
|
| Recruiting | 1 | 33 | US | ZM008, Antibody | Zumutor Biologics Inc. | Non Small Cell Lung Cancer, Esophageal Cancer, Head and Neck Squamous Cell Carcinoma, Pancreas Adenocarcinoma, Biliary Tract Cancer, Prostate Cancer, Urothelial Carcinoma, Colorectal Cancer, Triple Negative Breast Cancer, High Grade Ovarian Serous Adenocarcinoma, Diffuse Large B Cell Lymphoma | 12/26 | 04/27 | | |
| King, Brett |
BRAVE-AA1, NCT03570749: A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata |
|
|
| Active, not recruiting | 2/3 | 824 | Japan, US, RoW | Baricitinib, LY3009104, Placebo | Eli Lilly and Company, Incyte Corporation | Alopecia Areata | 02/21 | 01/25 | | |
|
|
| Active, not recruiting | 2 | 57 | US | AMG 714, Placebo, nbUVB phototherapy, narrow band ultraviolet B phototherapy | National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN), PPD DEVELOPMENT, LP, Rho Federal Systems Division, Inc., Amgen | Vitiligo | 10/24 | 04/25 | | |
| Smart, Frank |
NCT05592275: A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF) |
|
|
| Active, not recruiting | 2 | 456 | Europe, Canada, Japan, US, RoW | LY3540378, Placebo | Eli Lilly and Company | Heart Failure, Heart Failure With Preserved Ejection Fraction | 01/25 | 01/25 | | |
DETECT-HF, NCT06378632: AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM |
|
|
| Recruiting | N/A | 500 | Europe, US, RoW | Hearo App | Cordio Medical | Heart Failure | 01/25 | 03/25 | | |
| Wibbenmeyer, Lucy |
NCT04040660: Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries |
|
|
| Approved for marketing | N/A | | US | NexoBrid | MediWound Ltd | Thermal Burn | | | | |
| Recruiting | N/A | 240 | US | DeepView SnapShot Portable (DV-SSP) | SpectralMD | Burns, Wound Heal, Wounds and Injuries | 03/25 | 04/25 | | |
| Phelan, Herb |
| Completed | N/A | 109 | US | RECELL® Autologous Cell Harvesting Device, Spray-On SkinTM Cells | Avita Medical | Vitiligo | 07/24 | 01/25 | | |
| Chang, Jimmin |
NCT05821101: Clinical Outcomes of Clareon Vivity Intraocular Lens With Mini-Monovision Approach |
|
|
| Recruiting | N/A | 30 | US | Clareon Vivity and Clareon Vivity Toric IOLs targeted for mini-monovision with dominant eye set at emmetropia and non-dominant eye at -0.50. | Debbie S. Kuo, MD, Alcon Research | Aphakia, Postcataract | 12/25 | 06/26 | | |
| Completed | N/A | 109 | US | RECELL® Autologous Cell Harvesting Device, Spray-On SkinTM Cells | Avita Medical | Vitiligo | 07/24 | 01/25 | | |
| Smith, Alison |
| Recruiting | N/A | 800 | US | Myriad Matrix™ and Myriad Morcells™ | Aroa Biosurgery Limited | Abdominal Wound Dehiscence, Necrotizing Soft Tissue Infection, Lower Extremity Wound, Pilonidal Sinus, Anal Fistula, Hidradenitis Suppurativa, Pressure Injury | 01/28 | 01/29 | | |
| Lennard, Shana |
| Completed | N/A | 18 | US | Burn | SpectralMD | Burns | 01/24 | 01/24 | | |
| Recruiting | N/A | 240 | US | DeepView SnapShot Portable (DV-SSP) | SpectralMD | Burns, Wound Heal, Wounds and Injuries | 03/25 | 04/25 | | |
NCT05877638: SWC for Treatment of Superficial Partial-Thickness Burns |
|
|
| Terminated | N/A | 2 | US | SynePure Wound Cleanser and Catasyn Advanced Technology Hydrogel, SILVADENE Cream 1% (silver sulfadiazine) | Synedgen, Inc., Louisiana State University Health Sciences Center in New Orleans | Burn Wounds | 06/24 | 06/24 | | |
| Completed | N/A | 109 | US | RECELL® Autologous Cell Harvesting Device, Spray-On SkinTM Cells | Avita Medical | Vitiligo | 07/24 | 01/25 | | |
| Lau, Frank |
| Recruiting | N/A | 800 | US | Myriad Matrix™ and Myriad Morcells™ | Aroa Biosurgery Limited | Abdominal Wound Dehiscence, Necrotizing Soft Tissue Infection, Lower Extremity Wound, Pilonidal Sinus, Anal Fistula, Hidradenitis Suppurativa, Pressure Injury | 01/28 | 01/29 | | |
| Carter, Jeffrey |
| Completed | N/A | 109 | US | RECELL® Autologous Cell Harvesting Device, Spray-On SkinTM Cells | Avita Medical | Vitiligo | 07/24 | 01/25 | | |
| Ahoubim, Shawn |
NCT06393452: Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA |
|
|
| Active, not recruiting | 2 | 78 | US | PP405 0.05% Topical Gel, PP405 Topical Vehicle Gel | Pelage Pharmaceuticals, Inc. | Androgenetic Alopecia | 11/25 | 12/25 | | |
NCT05399368: An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis |
|
|
| Terminated | 2 | 229 | Canada, US | RPT193, Placebo | RAPT Therapeutics, Inc. | Atopic Dermatitis | 05/24 | 05/24 | | |
| Completed | N/A | 109 | US | RECELL® Autologous Cell Harvesting Device, Spray-On SkinTM Cells | Avita Medical | Vitiligo | 07/24 | 01/25 | | |
| Phelan, Herbert |
NCT05023135: DeepView SnapShot Portable (DV-SSP): Device Training Study |
|
|
| Completed | N/A | 251 | US | DeepView SnapShot Portable (DV-SSP) | SpectralMD | Burns, Wound Heal | 04/23 | 04/23 | | |
| Hart, Jennifer |
VAYHIA, NCT05648968: A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia |
|
|
| Recruiting | 3 | 90 | Europe, Japan, US, RoW | Ianalumab, VAY736, Placebo | Novartis Pharmaceuticals | Warm Autoimmune Hemolytic Anemia (wAIHA) | 03/26 | 02/29 | | |
| Fusco, Dahlene |
NCT04956445: Collection of SARS CoV-2 (COVID-19) Virus Secretions and Serum for Countermeasure Development |
|
|
| Recruiting | N/A | 2000 | US | | Tulane University, Centers for Disease Control and Prevention, Gilead Sciences | Covid19 | 03/25 | 03/25 | | |
| Paulsen, Alba Lucia |
| Recruiting | N/A | 240 | US | DeepView SnapShot Portable (DV-SSP) | SpectralMD | Burns, Wound Heal, Wounds and Injuries | 03/25 | 04/25 | | |
